The improbable plunge. What facts refute reasons to expect that the effectiveness of HPV vaccination programs to prevent cervical cancer could be low? (Q57388789)

From Wikidata

Jump to navigation Jump to search

article by Miquel Porta published May 2009 in Preventive Medicine

Language	Label	Description	Also known as
English	The improbable plunge. What facts refute reasons to expect that the effectiveness of HPV vaccination programs to prevent cervical cancer could be low?	article by Miquel Porta published May 2009 in Preventive Medicine

Statements

scholarly article

0 references

0 references

The improbable plunge. What facts refute reasons to expect that the effectiveness of HPV vaccination programs to prevent cervical cancer could be low? (English)

0 references

cervix uterine cancer

1 reference

based on heuristic

inferred from title

object named as

Miquel Porta

1

0 references

language of work or name

0 references

publication date

May 2009

0 references

Preventive Medicine

0 references

48

0 references

5

0 references

407-410

0 references

Stage of adoption of the human papillomavirus vaccine among college women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996-2000).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Human papillomavirus vaccine--opportunity and challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

HPV and cervical cancer: screening or vaccination?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Human Papillomavirus Vaccination — Reasons for Caution

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Defining a strategy to evaluate cervical cancer prevention and early detection in the era of HPV vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Human papillomavirus, vaccines and women's health: questions and cautions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Primary and Secondary Prevention of Cervical Cancer--Opportunities and Challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Medical societies' recommendations for immunization with Human Papillomavirus vaccine and disclosure of conflicts of interests

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Should an epidemiologist also have been awarded the 2008 Nobel Prize in Medicine?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Epidemiology: bridges over (and across) roaring levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

"Omics" research, monetization of intellectual property and fragmentation of knowledge: can clinical epidemiology strengthen integrative research?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Economic evaluations of massive HPV vaccination: within-study and between study variations in incremental cost per QALY gained.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Assessing the HPV vaccine: researchers confront complex interplay of factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Push to mandate HPV vaccine triggers backlash in USA

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Anticipated shame and worry following an abnormal Pap test result: the impact of information about HPV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Public health, public trust and lobbying.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Present choices, future outcomes: anticipated regret and HPV vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.04.004

7 January 2021

Identifiers

10.1016/J.YPMED.2009.04.004

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57388789&oldid=2043557082"